Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance

Xinlin Jiao(Qilu Hospital of Shandong University), Baoxia Cui(Qilu Hospital of Shandong University)

Clinical Epigenetics

August 19, 2019

10.1186/s13148-019-0719-9

Cited by 115

Related Papers

Therapeutic Potential of IL‐37 in Cervical Cancer: Suppression of Tumour Progression and Enhancement of CD47‐Mediated Macrophage Phagocytosis

|Molecular Carcinogenesis|2024|2